Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Lutetium-177

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Lutathera

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 445

    2019 Revenue in Millions : 441

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 475

    2020 Revenue in Millions : 445

    Growth (%) : 7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 471

    2021 Revenue in Millions : 475

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 605

    2022 Revenue in Millions : 471

    Growth (%) : 28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 724

    2023 Revenue in Millions : 605

    Growth (%) : 20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 167

    2017 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Lutathera

    Lutetium Lu 177 Dotatate

    arrow
    BIO Partnering at JPM
    Not Confirmed

    Brand Name : Lutathera

    Switzerland
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Novartis

    Lutetium Lu 177 Dotatate

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 441

    2018 Revenue in Millions : 167

    Growth (%) : 164

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.